---
title: "Shire Pharmaceuticals Group — Ownership Dossier"
canonical: https://whiteintel.dev/entity/5de76c4e-4bec-4a6b-bf6b-035cebbf7036
json: https://whiteintel.dev/api/public/dossier/5de76c4e-4bec-4a6b-bf6b-035cebbf7036
identifier: gb-coh:2883758
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Shire Pharmaceuticals Group

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:2883758`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/5de76c4e-4bec-4a6b-bf6b-035cebbf7036  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/5de76c4e-4bec-4a6b-bf6b-035cebbf7036  

## Cross-source identity

The same real-world entity, resolved across sources:

- **Shire Pharmaceuticals Group** — source · `gb-coh:02883758` — https://whiteintel.dev/entity/3cee557a-e52e-4175-a1ce-e58b6379c4d4
- **SHIRE PHARMACEUTICALS GROUP** — GLEIF · `lei:549300QSP5QPUO6EQ075` — https://whiteintel.dev/entity/b6c31931-5661-5f94-99d1-762cd9ecd8cc

## Ownership & control

### Holdings / subsidiaries

- **SHIRE PHARMACEUTICAL CONTRACTS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/01a09c7e-7609-5bb8-8de6-b328847a1425
- **Shire Plc** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/bdb5d519-5cad-53e9-957f-e3412b63d0ae
- **Takeda Pharmaceutical Company Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/c6d66986-6ed3-5e51-9314-2bfb98437f5f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Shire Pharmaceuticals Group**. Human view: https://whiteintel.dev/entity/5de76c4e-4bec-4a6b-bf6b-035cebbf7036 · Structured JSON: https://whiteintel.dev/api/public/dossier/5de76c4e-4bec-4a6b-bf6b-035cebbf7036._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._